10.25670/oi2018-001on Grošelj, Blaž Blaž Grošelj Onkološki inštitut Ljubljana Oražem, Miha Miha Oražem Onkološki inštitut Ljubljana Kovač, Viljem Viljem Kovač Onkološki inštitut Ljubljana Onkološki inštitut Ljubljana 2018 Journal Article 610 Medical sciences; Medicine cancer cannabinoids 2018-06-20 1581-3215 The use of cannabis derivatives (cannabinoids) in oncology is sometimes indicated in the symptomatic treatment of nausea and vomiting, in pain management and in some neuropsychiatric disorders. In the recent years, there has been a growing interest in determining the anticancer effects of cannabinoids. Based on our clinical experience, we know that many patients use cannabinoids, among them also those with the aim of curing their disease. But despite the extensive and convincing data on the anticancer properties of cannabinoids from in vitro studies on cell cultures and studies on animal models, these properties have not (yet) been confirmed in a clinical trial. This paper summarises the currently available data on the potential of cannabinoid use in the clinical practice of oncology. Onkologija, leto XXII, št. 1, junij 2018 Onkologija, Volume XXII, No. 1, June 2018 sl pdf Creative Commons Attribution 4.0 International license (CC BY 4.0)